This inventor holds 1 USPTO granted patent. Top assignee: Schering Aktiengesellschaft. Active years: 1979.
Company Filing History:
Years Active: 1979
Title: Alfred Popper: Innovator in Microbiological Conversion
Introduction
Alfred Popper is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of microbiological conversion, particularly in the transformation of sterol derivatives.
Latest Patents
Popper holds a patent for the microbiological conversion of sterol derivatives to 5-androsten-17-one. This innovative process involves the conversion of sterol derivatives, characterized by specific chemical structures, into corresponding androsten-17-ones through the oxidative degradation activity of microorganisms, particularly from the genus Mycobacterium. The method also includes the cleavage of ether groups in certain compounds using alkanoic acid chlorides or anhydrides in the presence of a Lewis acid.
Career Highlights
Alfred Popper is associated with Schering Aktiengesellschaft, a prominent company in the pharmaceutical industry. His work has contributed to advancements in biochemistry and microbiology, showcasing the potential of microbial processes in chemical transformations.
Collaborations
Throughout his career, Popper has collaborated with notable colleagues, including Alfred Weber and Mario Kennecke. These partnerships have fostered innovation and research in their respective fields.
Conclusion
Alfred Popper's contributions to microbiological conversion highlight the intersection of biology and chemistry, paving the way for future innovations in the field. His patent and collaborations reflect a commitment to advancing scientific knowledge and practical applications.